Status:

UNKNOWN

NightWare Open Enrollment Study

Lead Sponsor:

NightWare

Collaborating Sponsors:

RationalPsych

Center for International Emergency Medical Services

Conditions:

PostTraumatic Stress Disorder

Sleep Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will provide measures of safety and efficacy of the NightWare digital therapeutic system (iPhone + Apple watch + proprietary application) for the treatment of nightmare disorder associated ...

Detailed Description

Nightmares are a common problem affecting 2-8% of the general population and a higher proportion of clinical populations. The negative consequences of untreated nightmares are significant and include ...

Eligibility Criteria

Inclusion

  • New to NightWare
  • Self report of diagnosis with PTSD
  • Self-report of PTSD-related repetitive nightmares contributing to disrupted sleep.
  • Equal to or older than 18 years of age.
  • Proficient in both reading and writing in the English language.
  • Pittsburgh Sleep Quality Index (PSQI) score equal to or greater than 10.
  • ESS: On question #8 any score above "0" will prompt an additional question:
  • Do you drive ("get behind the wheel") when you are drowsy?
  • Answer must be "No" to be enrolled in the study for safety.
  • Participant owns or has access to devices appropriate for participation in the study including compatible Apple Watch and Apple iPhone.
  • Wireless Internet and two power outlets where they sleep.
  • OR
  • Current NightWare user - Is a participant in current NightWare consumer preference study or has successfully completed any NightWare study protocol.

Exclusion

  • New to NightWare
  • Circadian rhythm disruption on a regular basis (shift-work)
  • Concurrent presence of prohibited diagnoses
  • Known diagnosis of OSA
  • Diagnosis of an active disorder of arousal from non-rapid eye movement sleep
  • Diagnosis of rapid eye movement sleep behavior disorder
  • Diagnosis of narcolepsy
  • Diagnosis of dementia
  • Uncontrolled atrial fibrillation
  • Use of Alcohol or Drugs as specified:
  • Alcohol Use Disorders Inventory Test (AUDIT) (score of 8 or higher)
  • Drug Abuse Screening Test-10 (DAST-10) (score greater than 2)
  • Suspicion of nightmares being secondary to substance abuse or withdrawal
  • Previous or foreseeable legal proceedings involving nightmares or trauma
  • Nocturia that causes awakening from sleep
  • Known sleep walking
  • Acting out of dreams PRIOR to PTSD trauma
  • Willingness not to use any other application which collects heart rate data on the phone and watch that is used for NightWare.
  • OR
  • Current NightWare User
  • \- No known adverse reaction to the use of the NightWare system.

Key Trial Info

Start Date :

February 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2022

Estimated Enrollment :

400 Patients enrolled

Trial Details

Trial ID

NCT03828656

Start Date

February 1 2019

End Date

February 1 2022

Last Update

March 4 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

RationalPsych

The Bronx, New York, United States, 10461